TD Cowen Upgrades Spero Therapeutics (SPRO) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Form S-8 Spero Therapeutics, Inc.
August 5, 2024 4:26 PM EDTAs filed with the Securities and Exchange Commission on August 5, 2024
Registration No. 333-
UNITED STATES
... MoreForm 8-K Spero Therapeutics, Inc. For: Aug 05
August 5, 2024 4:14 PM EDTfalse 0001701108 0001701108 2024-08-05 2024-08-05... More
